NRC Health· NRC
🇺🇸 US · MicroBroad USNASDAQ
- Price
- $19.59
- Day
- +0.46%
- Mkt Cap
- $441.49M
- 52W Range
- $11.01 – $23.68
- Volume
- 135.6K
- Beta
- 0.37
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
Read full article
NRC Health (NRC) Q2 2026 Earnings Call Transcript
Read full article
LINCOLN, Neb.--(BUSINESS WIRE)--NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the second quarter 2026. "Our second quarter was a success on many fronts, including double-digit TRCV growth over the prior year, strong go-to-market and solutions delivery execution, continued commercialization of our product innovations, and the strongest bookings performance for The Governance Institute in seven years, positioning us well for a stron.
Read full article
National Research NASDAQ: NRC, operating as NRC Health, reported second-quarter results marked by 11% year-over-year growth in total recurring contract value, while management said investments in implementation, customer success and product development supported a large customer deployment and future growth initiatives.
Read full article
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2026) - Nations Royalty Corp. (TSXV: NRC) (OTCQX: NRYCF) (FSE: Y96) ("Nations Royalty" or the "Company") is pleased to report financial results for the year ended March 31, 2026, and provide an update on key assets within its royalty portfolio. Highlights for Fiscal 2026 Royalty revenue increased 91% year-over-year to C$1.61 million, compared to C$0.84 million in Fiscal 2025.
Read full article
Fifth Third Bancorp acquired a new stake in shares of National Research Corporation (NASDAQ: NRC) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 90,182 shares of the company's stock, valued at approximately $1,531,000. Fifth Third Bancorp owned approximately
Read full article
Voluntary NRC readiness review to support 2026 SOLO™ Construction Permit Application and Terra's 2028 commercialization target Early review of draft safety and environmental documentation intended to identify issues in advance of formal submittal and strengthen application quality Preapplication engagement aligns with Terra's parallel construction permit and operating license strategy NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) (“Terra” or the “Company”), a developer of advanced micro-modular nuclear reactors, today announced that it has requested that the U.S. Nuclear Regulatory Commission (“NRC”) conduct a voluntary preapplication readiness review of the Company's planned SOLO™ Micro-Modular Reactor (“MMR™”) Construction Permit Application.
Read full article